Second Study In Two Months Touts Cannabis' Germ-Fighting Abilities
Share This Article
Oxford, MI: Non-cannabinoid constituents in marijuna possess anti-bacterial properties against malaria, methicillim-resistant Staphyloccus aureus (aka MRSA), and other potentially drug-resistant pathogens, according to findings to be published in the journal Phytochemistry.
Investigators at the University of Mississippi, National Center for Natural Products Research reported the discovery of eleven new non-cannabinoid constituents in cannabis, several of which possess strong "anti-microbial," "anti-malarial," and "anti-leishmanial" (a common skin parasite) activity. Scientists reported that several of the compounds also possessed anti-inflammatory properties and acted as potent anti-oxidants.
Commenting on the study, NORML Deputy Director Paul Armentano said, "Therapeutic cannabis means just that - the therapeutic prowess of the whole plant. We should not advocate for, or accept, anything less."
A previous study published online in August by the Journal of Natural Products reported that at least five cannabinoids - THC, CBD (cannabidiol), CBG (cannabigerol), CBC (cannabichromine), and CBN (cannabinol) - possess germ-killing abilities against various strains of multidrug-resistant bacteria, including MRSA.